Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

1(100.0%)

1Total

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05534958Completed

UK Validation of the Automated "AcceXible" Speech Analysis Software

Role: collaborator

NCT07393932Not Yet Recruiting

MND Together: Phase 1

Role: collaborator

NCT06451549Not ApplicableWithdrawn

Clinical Investigation of Syndi

Role: collaborator

NCT05835492Active Not Recruiting

A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD

Role: collaborator

NCT06354868Not Yet Recruiting

A Study to Assess utiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy

Role: collaborator

NCT05468541Completed

Psychological and Quality of Life Impact of Brain in Hand

Role: lead

NCT05384782Completed

Computational Decision Support in Epilepsy Using Retrospective EEG

Role: lead

All 7 trials loaded